Moderna's MRNA COVID-19 Vaccine Approved In Japan

Moderna, Inc. announced Friday that its mRNA COVID-19 vaccine has been approved in Japan for emergency use. Japan's Takeda Pharmaceutical Co. Ltd., which is in deal with Moderna, will begin the vaccine distribution in Japan immediately. Moderna's COVID-19 vaccine is authorized for emergency use in adults aged 18 years and older.

from RTT - Top Story https://ift.tt/3vbErjp
via IFTTT